TriangleNCT00589563 · OUTCOME
Occurrence of Thrombotic Microangiopathy
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- participants
- Interval / dispersion
- Not reported
- Time frame
- Median Follow Up: 28 Months (Range: 1-49 months)
What was measured
Participants were monitored throughout the trial (median of 28 months) for various infections/complications. This is the number of participants who developed TMA.
Groups in this outcome
All Patients
All patients were analyzed as a single population. Stratification by conditioning regimen was not done.
| Group | Source count |
|---|---|
| All Patients | 32 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| All Patients | 7 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 7
- denoms
- counts
- group Id
- OG000
- value
- 32
- units
- Participants
- description
- Participants were monitored throughout the trial (median of 28 months) for various infections/complications. This is the number of participants who developed TMA.
- groups
- description
- All patients were analyzed as a single population. Stratification by conditioning regimen was not done.
- id
- OG000
- title
- All Patients
- param Type
- NUMBER
- reporting Status
- POSTED
- time Frame
- Median Follow Up: 28 Months (Range: 1-49 months)
- title
- Occurrence of Thrombotic Microangiopathy
- type
- SECONDARY
- unit Of Measure
- participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice